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Possible involvement of T helper type 2 responses to
Toll-like receptor ligands in IgG4-related
sclerosing disease
Reiko Akitake, Tomohiro Watanabe, Chikage Zaima, Norimitsu Uza, Hiroshi Ida,
Shinsuke Tada, Naoshi Nishida, Tsutomu Chiba
ABSTRACT
We report a case of immunoglobulin G4 (IgG4)-related
sclerosing disease involving the pancreas, liver and
salivary glands. Massive infiltration of IgG4-expressing
plasma cells was seen in the liver and submandibular
lymph nodes. Interestingly, accumulation of IgG4-
expressing plasma cells was also seen in the colon and
terminal ileum. Peripheral blood mononuclear cells
(PBMCs) isolated from this patient exhibited enhanced
production of IgG4 and interleukin-10 upon stimulation
with Toll-like receptor (TLR) ligands as compared with
those from a healthy control. In contrast, production of
tumour necrosis factor a and interferon g by PBMCs
from this patient was markedly reduced. Since colonic
mucosa is always exposed to TLR ligands derived from
commensal organisms, the results of immunological
studies suggest that enhanced T helper type 2 responses
to intestinal microflora may underlie the
immunopathogenesis in this patient with IgG4-related
sclerosing disease.
INTRODUCTION
Autoimmune pancreatitis (AIP) is an inflammatory
disorder which is characterised by increased serum
levels of immunoglobulin G4 (IgG4) or by an IgG4-
positive plasmacytic infiltrate into the inflamed
tissue.1 Another important feature of AIP is a wide
variety of extrapancreatic manifestations such as
sialadenitis, cholangitis, retroperitoneal fibrosis and
inflammatory pseudotumour of the liver and lung.2
Since these extrapancreatic and pancreatic lesions
share common histopathological findings (ie, abun-
dant infiltration by IgG4+ plasmacytes), Kamisawa
et al proposed a new clinicopathological entity:
‘IgG4-related sclerosing disease’.2 However, little is
understood regarding the role played by this IgG
subtype in the inflammatory process. In this regard,
IgG4 itself does not seem to be responsible for the
development of tissue damage since this IgG
subtype does not cause cell-mediated lysis due to
poor binding activity to complement.3 In addition,
anti-inflammatory activity of IgG4 has been
shown.4 Consistent with these biological functions
of IgG4, clinical manifestations of immune complex
disease such as arthritis and glomerulonephritis are
rarely seen in patients with IgG4-related sclerosing
disease.5 These facts suggest that abnormal immu-
nological environments leading to enhanced IgG4
responses, rather than IgG4 antibody itself, underlie
the pathogenesis of this disease.
Distribution of IgG4-expressing plasmacytes in
the gastrointestinal tract of patients with AIP has
been observed.6 7 However, it is unknown whether
this distribution of IgG4+ cells is directly induced
by immune reactions occurring in the gastrointes-
tinal tract or is indirectly induced by systemic IgG4
responses. Given the fact that mucosa of the
gastrointestinal tract is always exposed to antigens
derived from intestinal microflora, it is tempting to
speculate that immune responses against microbial
antigens create abnormal environments leading to
enhanced IgG4 responses in the gut. Indeed, we
experienced a case of IgG4-related sclerosing disease
in which accumulation of IgG4-expressing plas-
macytes was visualised as colonic inflammatory
pseudopolyps.8 Here we report a case with IgG4-
related sclerosing disease whose ileal and colonic
mucosa bore a marked infiltration of IgG4-
expressing plasma cells. Interestingly, peripheral
blood mononuclear cells (PBMCs) isolated from
this case show enhanced T helper type 2 (Th2) and
IgG4 responses upon stimulation with Toll-like
receptor (TLR) ligands. These results indicate
possible involvement of excessive Th2 responses
against intestinal microflora in some cases with
IgG4-related sclerosing disease.
CASE REPORT
A 70-year-old asymptomatic man was admitted for
further investigation of swelling of the pancreas
and submandibular lymph nodes. He had a history
of systemic lymphadenopathy of unknown aeti-
ology at the age of 45. Laboratory tests revealed
elevation of serum levels of amylase (229 IU/l;
normal range <129 IU/l) and IgG (2144 mg/dl;
normal range <1840 mg/dl). Abdominal CT using
contrast reagent showed focal swelling of the
pancreatic head without an enhancement effect.
Endoscopic retrograde cholangiopancreatography
revealed irregular narrowing of the main pancreatic
duct and the stricture of the lower bile duct. These
radiographic findings were consistent with those of
AIP.1 A hypoechoic tumour was detected in the
lateral segment of the liver on abdominal ultraso-
nography. Since a marked elevation of serum IgG4
level was detected (918 mg/dl; normal range
<135 mg/dl), this patient was strongly suspected
to have IgG4-related screlosing disease involving
the pancreas, bile duct and liver. Biopsy of the liver
tumour revealed massive infiltration of plasmacytes
expressing IgG and IgG4 around the bile duct
(figure 1). More than 50% of IgG-expressing cells
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were positive for IgG4 staining, which suggests that this liver
tumour was a pseudotumour due to IgG4-associated cholangitis.
Similar histological findings were obtained in the immunohis-
tochemical analyses using biopsy specimens from submandib-
ular lymph nodes (figure 1). Based on these results, this patient
was finally diagnosed as having IgG4-related sclerosing disease.
Colonoscopy was performed to exclude the involvement of
the gastrointestinal tract before starting prednisolone treatment.
Although no inflammatory mucosa was seen from the terminal
ileum to the rectum on colonoscopic examination, biopsy
specimens taken from the intact mucosa of the terminal ileum
and colon revealed a marked infiltration of plasmacytes
expressing IgG into the submucosa without destruction of crypt
architecture or fibrosis (figure 1). Interestingly, >50% of IgG-
expressing cells were positive for IgG4 staining. Accumulation of
IgG4-expressing plasma cells in the colonic mucosa led us to
hypothesise that abnormal immunological responses to gut
microbial antigens might underlie the development of enhanced
IgG4 responses. PBMCs from this case and healthy controls were
stimulated with TLR ligands to see immune responses against
antigens derived from intestinal microflora.9 Ethical permission
for this study was granted by the review board of Kyoto
University. As shown in figure 2, production of IgG4 as well as
interleukin-10 (IL-10) was enhanced upon stimulation with
TLR4 (lipopolysaccharide (LPS)) and TLR5 (flagellin) ligands.
Production of IgG4 was also enhanced by stimulation of a TLR2
ligand (peptidoglycan (PGN)). In contrast, production of Th1
cytokines (interferon g (IFNg) and tumour necrosis factor
a (TNFa)) in response to TLR ligands by the patient’s PBMCs
was impaired as compared with that by control PBMCs. No
difference was seen in the production of IL-8 or IL-17 upon
stimulation with TLR ligands or TNFa. These data suggest that
activation of TLRs generates both IgG4 and Th2 responses in
PBMCs from this case since IFNg and IL-10 are prototypical Th1
and Th2 cytokines, respectively.9 We determined the type of
immune cells producing these cytokines by cell depletion study
Figure 1 Immunohistochemical
staining of immunoglobulin G4 (IgG4)
and IgG. Biopsy specimens obtained
from the liver, submandibular lymph
nodes, terminal ileum and colon were
stained with anti-IgG4 or anti-IgG
antibody for visualisation of plasma
cells expressing IgG4 or IgG.
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using control samples. We found that CD3+ T cells produced
IFNg and IL-10 whereas CD14+ monocytes produced IL-10 and
TNFa (data not shown).
DISCUSSION
An interesting observation in this case with IgG4-related scle-
rosing disease was a marked infiltration of IgG4-expressing
plasmacytes into the colonic mucosa which appeared to be
normal on endoscopic examination. It remains unclear whether
we can regard this case as IgG4-related sclerosing disease
involving the colonic mucosa since no pathological findings were
present in colonic biopsy specimens other than marked infil-
tration of IgG4+ cells. Thus, unlike our previous case in which
infiltration of IgG4-expressing plasmacytes was visualised as
colonic polypoidal lesions,8 we have to be cautious in the
interpretation of infiltration of IgG4-expressing plasma cells into
endoscopically normal colonic mucosa in the setting of IgG4-
related sclerosing disease.
Immune responses leading to accumulation of IgG4-
expressing plasmacytes in the gastrointestinal tract are poorly
understood. PBMCs isolated from this case exhibited enhanced
production of IgG4 and Th2 cytokines upon stimulation with
TLR ligands, suggesting that enhanced immune reactions
against microbial antigens cause infiltration of lymphocytes as
in the case of inflammatory bowel disease (IBD).10 In fact, this
idea is supported by clinical evidence that a significant popula-
tion of patients with AIP have a diagnosis of IBD.11 Importantly,
IgG4 responses induced by TLR activation are associated with
enhanced IL-10 production. In this regard, two different groups
report involvement of regulatory T cells (Tregs) producing IL-10
in IgG4-related sclerosing disease.12 13 Thus, enhanced IL-10
production seen in this case may be partially mediated by
circulating Tregs. Given the fact that IL-10 is an important
cytokine for IgG4 class switching,14 we assume that excessive
Th2 responses triggered by TLR ligands together with activation
of Tregs create abnormal immunological environments leading
to enhanced IgG4 responses. This idea partially explains
immunological mechanisms of enhanced Th2 responses in
patients with IgG4-related sclerosing disease.12
Although storiform fibrosis is a characteristic pathological
finding of IgG4-related sclerosing disease,2 molecular mecha-
nisms of fibrosis in this disorder are poorly understood. Th2
cytokines mediated by activation of TLRs on macrophages have
been identified as positive regulators of tissue fibrosis in the liver
and lung.15 Thus, enhanced Th2 responses to TLR ligands might
be involved in the development of storiform fibrosis in IgG4-
related sclerosing disease. However, analysis of expression of
both Th2 cytokines and TLRs using fibrotic tissue samples is
necessary to address this issue.
What is the mechanism by which enhanced Th2 responses
against intestinal microflora cause IgG4-related sclerosing disease
without the development of colitis? In this regard, immune
reactions causing tissue injury and those causing IgG4 responses
should be considered separately as shown by the fact that IgG4
antibody itself has anti-inflammatory properties.4 Indeed, tissue
destruction was not seen in the lower gastrointestinal tract of
this case despite a marked infiltration of IgG4-expressing plas-
macytes into the submucosa. Several mechanisms for preventing
hyper-responsiveness to microbial antigens operate in the gut.
For example, the intestine is the preferential site where naïve T
cells differentiate into Tregs.10 Thus, one possible explanation is
that pathogenic immune reactions causing tissue injury are
suppressed in the gut by regulatory mechanisms, whereas such
reactions cause tissue injury in other sterile organs such as the
pancreas and bile duct due to the lack of regulatory mechanisms.
Based on this, it is tempting to speculate that the gastrointes-
tinal tract is an induction site for systemic IgG4 responses and
functions as a reservoir for IgG4-expressing plasmacytes even if
disease-associated pathogenic changes are absent. Alternatively,
distribution of IgG4-expressing plasmacytes into the colonic
mucosa may be an epiphenomenon associated with systemic
IgG4 responses.
In conclusion, the results of immunological studies using
PBMCs from this case suggest involvement of excessive Th2
responses to intestinal microflora in the development of IgG4-
related sclerosing disease. Confirmation of this idea awaits
further studies using a large number of patients with IgG4-
related sclerosing disease.
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Figure 2 Enhanced T helper type 2
(Th2) responses to Toll-like receptor
(TLR) ligands by peripheral blood
mononuclear cells (PBMCs) isolated
from the patient. PBMCs (23106/ml)
isolated from the patient and healthy
controls were stimulated with
peptidoglycan (PGN, 10 mg/ml),
lipopolysaccharide (LPS, 1 mg/ml),
flagellin (1 mg/ml) or tumour necrosis
factor (TNF, 20 ng/ml). PBMCs were
cultured for 48 h for interleukin-8 (IL-8)
and TNF assay, and for 14 days for
IgG4, interferon g (IFNg), IL-10 and
IL-17 assay. Results shown are means
of triplicate wells.
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